کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2121624 1547090 2015 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up
ترجمه فارسی عنوان
پرتودرمانی با مدولاسیون شدت بقای بیمار مبتلا به کارسینوم نازوفارنکس در مقایسه با رادیوتراپی دو بعدی معمولی را افزایش می دهد: یک تجربه 10 ساله با یک گروه بزرگ و پیگیری طولانی
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی تحقیقات سرطان
چکیده انگلیسی


• IMRT is superior to 2D-CRT in improving quality of life in treating NPC patients.
• However, the survival benefits were inconsistent in different reports.
• We first compared the efficacy of IMRT and 2D-CRT based on a largest cohort (n = 7081).
• IMRT is more effective in improving LRFS, LRRFS and PFS compared with 2D-CRT.
• Our results provide important data on the potential benefits of IMRT in NPC.

BackgroundTo evaluate the survival benefit of intensity-modulated radiotherapy (IMRT) compared with conventional two-dimensional radiotherapy (2D-CRT) in nasopharyngeal carcinoma (NPC) using a large cohort with long follow-up.MethodsWe retrospectively analysed 7081 non-metastatic NPC patients who received curative IMRT or 2D-CRT from February 2002 to December 2011.ResultsOf the 7081 patients, 2245 (31.7%) were administered IMRT, while 4836 (68.3%) were administered 2D-CRT. At 5 years, the patients administered IMRT had significantly higher local relapse-free survival (LRFS), loco-regional relapse-free survival (LRRFS), progression-free survival (PFS) and overall survival (OS) (95.6%, 92.5%, 82.1% and 87.4%, respectively) than those administered 2D-CRT (90.8%, 88.5%, 76.7% and 84.5%, respectively; p < 0.001). The distant metastasis-free survival (DMFS) was higher for IMRT than 2D-CRT, with borderline significance (87.6% and 85.7%, respectively; p = 0.056). However, no difference was observed between IMRT and 2D-CRT in nodal relapse-free survival (NRFS; 96.3% and 97.4%, respectively; p = 0.217). Multivariate analyses showed that IMRT was an independent protective prognostic factor for LRFS, LRRFS and PFS, but not NRFS, DMFS or OS.ConclusionsIMRT provided an improved LRFS, LRRFS and PFS in both the early and advanced T classifications and overall stage for non-disseminated NPC compared with 2D-CRT. However, no significant advantage was observed in NRFS, DMFS or OS when IMRT was used.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Cancer - Volume 51, Issue 17, November 2015, Pages 2587–2595
نویسندگان
, , , , , , , , , , , ,